267 related articles for article (PubMed ID: 27340177)
1. Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland.
Annunziato S; Kas SM; Nethe M; Yücel H; Del Bravo J; Pritchard C; Bin Ali R; van Gerwen B; Siteur B; Drenth AP; Schut E; van de Ven M; Boelens MC; Klarenbeek S; Huijbers IJ; van Miltenburg MH; Jonkers J
Genes Dev; 2016 Jun; 30(12):1470-80. PubMed ID: 27340177
[TBL] [Abstract][Full Text] [Related]
2. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.
Derksen PW; Liu X; Saridin F; van der Gulden H; Zevenhoven J; Evers B; van Beijnum JR; Griffioen AW; Vink J; Krimpenfort P; Peterse JL; Cardiff RD; Berns A; Jonkers J
Cancer Cell; 2006 Nov; 10(5):437-49. PubMed ID: 17097565
[TBL] [Abstract][Full Text] [Related]
3. PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma.
Boelens MC; Nethe M; Klarenbeek S; de Ruiter JR; Schut E; Bonzanni N; Zeeman AL; Wientjens E; van der Burg E; Wessels L; van Amerongen R; Jonkers J
Cell Rep; 2016 Aug; 16(8):2087-2101. PubMed ID: 27524621
[TBL] [Abstract][Full Text] [Related]
4. mILC-ing the mouse mammary gland: A model for invasive lobular carcinoma.
Alvarez JV; Perez D; Chodosh LA
Cancer Cell; 2006 Nov; 10(5):347-9. PubMed ID: 17097555
[TBL] [Abstract][Full Text] [Related]
5. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW
J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524
[TBL] [Abstract][Full Text] [Related]
6. Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice.
Derksen PW; Braumuller TM; van der Burg E; Hornsveld M; Mesman E; Wesseling J; Krimpenfort P; Jonkers J
Dis Model Mech; 2011 May; 4(3):347-58. PubMed ID: 21282721
[TBL] [Abstract][Full Text] [Related]
7. In situ CRISPR-Cas9 base editing for the development of genetically engineered mouse models of breast cancer.
Annunziato S; Lutz C; Henneman L; Bhin J; Wong K; Siteur B; van Gerwen B; de Korte-Grimmerink R; Zafra MP; Schatoff EM; Drenth AP; van der Burg E; Eijkman T; Mukherjee S; Boroviak K; Wessels LF; van de Ven M; Huijbers IJ; Adams DJ; Dow LE; Jonkers J
EMBO J; 2020 Mar; 39(5):e102169. PubMed ID: 31930530
[TBL] [Abstract][Full Text] [Related]
8. ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
Ping Z; Siegal GP; Harada S; Eltoum IE; Youssef M; Shen T; He J; Huang Y; Chen D; Li Y; Bland KI; Chang HR; Shen D
Oncotarget; 2016 Dec; 7(49):80655-80663. PubMed ID: 27811364
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations.
Grabenstetter A; Mohanty AS; Rana S; Zehir A; Brannon AR; D'Alfonso TM; DeLair DF; Tan LK; Ross DS
Hum Pathol; 2020 Aug; 102():44-53. PubMed ID: 32599083
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
Zou D; Yoon HS; Perez D; Weeks RJ; Guilford P; Humar B
J Pathol; 2009 Jun; 218(2):265-72. PubMed ID: 19294736
[TBL] [Abstract][Full Text] [Related]
11. Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing.
Yoo KH; Hennighausen L; Shin HY
J Mammary Gland Biol Neoplasia; 2019 Mar; 24(1):47-59. PubMed ID: 30291498
[TBL] [Abstract][Full Text] [Related]
12. Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma.
Kas SM; de Ruiter JR; Schipper K; Annunziato S; Schut E; Klarenbeek S; Drenth AP; van der Burg E; Klijn C; Ten Hoeve JJ; Adams DJ; Koudijs MJ; Wesseling J; Nethe M; Wessels LFA; Jonkers J
Nat Genet; 2017 Aug; 49(8):1219-1230. PubMed ID: 28650484
[TBL] [Abstract][Full Text] [Related]
13. Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships.
Sakr RA; Schizas M; Carniello JV; Ng CK; Piscuoglio S; Giri D; Andrade VP; De Brot M; Lim RS; Towers R; Weigelt B; Reis-Filho JS; King TA
Mol Oncol; 2016 Feb; 10(2):360-70. PubMed ID: 26643573
[TBL] [Abstract][Full Text] [Related]
14. Truncated ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via Distinct Mechanisms.
Schipper K; Drenth AP; van der Burg E; Cornelissen S; Klarenbeek S; Nethe M; Jonkers J
Cancer Res; 2020 Apr; 80(7):1486-1497. PubMed ID: 32060147
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer.
Teo K; Gómez-Cuadrado L; Tenhagen M; Byron A; Rätze M; van Amersfoort M; Renes J; Strengman E; Mandoli A; Singh AA; Martens JH; Stunnenberg HG; van Diest PJ; Brunton VG; Derksen PWB
Sci Rep; 2018 Oct; 8(1):15454. PubMed ID: 30337563
[TBL] [Abstract][Full Text] [Related]
16. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
[TBL] [Abstract][Full Text] [Related]
17. Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells.
Chen F; Ding K; Priedigkeit N; Elangovan A; Levine KM; Carleton N; Savariau L; Atkinson JM; Oesterreich S; Lee AV
Cancer Res; 2021 Jan; 81(2):268-281. PubMed ID: 33148662
[TBL] [Abstract][Full Text] [Related]
18. In vivo genome-editing screen identifies tumor suppressor genes that cooperate with Trp53 loss during mammary tumorigenesis.
Heitink L; Whittle JR; Vaillant F; Capaldo BD; Dekkers JF; Dawson CA; Milevskiy MJG; Surgenor E; Tsai M; Chen HR; Christie M; Chen Y; Smyth GK; Herold MJ; Strasser A; Lindeman GJ; Visvader JE
Mol Oncol; 2022 Mar; 16(5):1119-1131. PubMed ID: 35000262
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
Sarrió D; Moreno-Bueno G; Hardisson D; Sánchez-Estévez C; Guo M; Herman JG; Gamallo C; Esteller M; Palacios J
Int J Cancer; 2003 Aug; 106(2):208-15. PubMed ID: 12800196
[TBL] [Abstract][Full Text] [Related]
20. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
Turashvili G; Bouchal J; Baumforth K; Wei W; Dziechciarkova M; Ehrmann J; Klein J; Fridman E; Skarda J; Srovnal J; Hajduch M; Murray P; Kolar Z
BMC Cancer; 2007 Mar; 7():55. PubMed ID: 17389037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
